Dr. Jin Huang from the Huazhong University of Science and Technology in China conducted research on the effect of alcohol consumption in type 2 diabetes (T2D) patients. The research study results show that wine is more helpful compared with other beer or spirits for type ii diabetes. There may be a greater risk for severe hypoglycemia if more alcohol is consumed. The results were published in the Journal of Diabetes Investigation.
iGlarLixi, a type 2 diabetes (T2D) combination drug manufactured by Zealand Pharma A/S and this drug was recommended for approval by US panel. Manufacturers say the drug is under regulatory review in Europe. The drug is a combination of Sanofi's Lantus (insulin glargine) and the GLP-1 drug Lyxumia (lixisenatide) and it is diabetes therapy drug. Patients who are taking insulin or a GLP-1 drug would be given preference. Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) approved Novo Nordisk drug (named as IDegLira), which is similar to iGlarLixi.
Researchers and scientists at The University of Texas Medical Branch (UTMB) at Galveston found a molecular mechanism involved in diabetic cardiomyopathy in diabetic patients. Heart problems are the number one cause of death for diabetes patients. Diabetes patients have a higher risk of developing cardiovascular diseases. This happens due to a damage to the heart muscle which prevents the heart from circulating blood properly. Researchers identified RBFOX2 function. This research finding could lead to design better tools to manage diabetic cardiomyopathy in future. Lead author of the team is N Muge Kuyumcu-Martinez, and he is an Asst Professor in UTMB. The findings were published in Journal Cell Reports.
American researchers examined 197 children (aged between 7 and 18 Years) suffering from type 1 diabetes (T1D) for a relationship between glycemic control and blood glucose levels. Researchers belong to University of Pennsylvania School of Nursing. The study says there is no relationship between glycemic control and vitamin D levels in children between age 7 and 18 years. Researchers found deficiency of 25-hydroxyvitamin (hydroxy vitamin) D among healthy weight and Caucasian children. Authors say research data emphasize the importance of screening 25-hydroxyvitamin D levels in all youth with type 1 diabetes. The research findings were published in Diabetes Research and Clinical Practice.
Scientists led by Dr. Michael Christie from the University of Lincoln, the UK, identified unknown molecule which is attacked by our immune system in people with type 1 diabetes (T1D). Scientists are trying to identify the fifth molecule for the past 20 years. Previous studies indicated that there are 5 key targets that our immune system attacks in the development of type 1 diabetes (T1D) and discovered 4 molecules. They are
The newly identified 5th molecule was known as Glima previously. Now scientists found that it is human protein, and named it Tetraspanin-7. With Tetraspanin-7 molecule, people with type 1 diabetes risk can be identified better. The findings were published in Diabetes, the journal of the American Diabetes Association.
In an event hosted by Copeland MP Jamie Reed and the Home Secretary Theresa May, JDRF announced that £97m will be spent on diabetes research in the UK. The money is being provided by 7 funders.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.